2-Year U.S. Treasury Note Continuous Contract $103.484 0.164 0.16% 5-Year U.S. Treasury Note Continuous Contract $107.953 0.352 0.33% 10-Year U.S. Treasury Note Continuous Contract $111.109 0.469 ...
Altimmune's pemvidutide shows promise in treating MASH and obesity, with upcoming Phase 2b results poised to shape its market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback